首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7593篇
  免费   528篇
  国内免费   15篇
耳鼻咽喉   100篇
儿科学   252篇
妇产科学   164篇
基础医学   910篇
口腔科学   75篇
临床医学   1010篇
内科学   1350篇
皮肤病学   112篇
神经病学   724篇
特种医学   183篇
外科学   812篇
综合类   75篇
一般理论   3篇
预防医学   1096篇
眼科学   217篇
药学   483篇
中国医学   5篇
肿瘤学   565篇
  2024年   8篇
  2023年   71篇
  2022年   137篇
  2021年   268篇
  2020年   170篇
  2019年   202篇
  2018年   262篇
  2017年   205篇
  2016年   197篇
  2015年   236篇
  2014年   314篇
  2013年   441篇
  2012年   622篇
  2011年   655篇
  2010年   365篇
  2009年   322篇
  2008年   500篇
  2007年   481篇
  2006年   442篇
  2005年   479篇
  2004年   423篇
  2003年   376篇
  2002年   326篇
  2001年   53篇
  2000年   40篇
  1999年   44篇
  1998年   44篇
  1997年   53篇
  1996年   28篇
  1995年   23篇
  1994年   16篇
  1993年   8篇
  1992年   18篇
  1991年   20篇
  1990年   18篇
  1989年   11篇
  1988年   17篇
  1987年   8篇
  1986年   24篇
  1985年   18篇
  1984年   16篇
  1983年   24篇
  1982年   16篇
  1981年   14篇
  1980年   10篇
  1979年   15篇
  1978年   10篇
  1976年   10篇
  1975年   9篇
  1970年   11篇
排序方式: 共有8136条查询结果,搜索用时 15 毫秒
81.
82.
BackgroundWe assessed if the risk of post-liver transplant mortality within 24 h could be stratified at the time of listing using the liver transplant risk score (LTRS). Secondary aims were to assess if the LTRS could stratify the risk of 30-day, 1-year mortality, and survival beyond the first year.MethodsMELD, BMI, age, diabetes, and the need for dialysis were the five variables used to calculate the LTRS during patients' evaluation for liver transplantation. Mortality rates at 24 h, 30 days, and 1-year were compared among groups of patients with different LTRS. Patients with ABO-incompatibility, redo, multivisceral, partial graft and malignancies except for hepatocellular carcinoma were excluded. Data of 48,616 adult liver transplant recipients were extracted from the Scientific Registry of Transplant Recipients between 2002 and 2017.Results24-h mortality was 0.9%, 1.0%, 1.1%, 1.7%, 2.3%, 2.0% and 3.5% for patients with LTRS of 0,1,2,3,4, 5 and ≥ 6, respectively (P < 0.001). 30-day mortality was 3.5%, 4.2%, 4.9%, 6.2%, 7.6%, 7.2% and 10.1% respectively (P < 0.001). 1-year mortality was 8.6%, 10.8%, 12.9%, 13.9%, 18.5%, 20.3% and 28.6% respectively (P < 0.001). 10-year survival was 61%, 56%, 57%, 54%, 47%, and 31% for patients with 0, 1, 2, 3, 4, 5 and ≥ 6 points respectively (P < 0.001).ConclusionPerioperative mortality and long-term survival of patients undergoing LT can be accurately estimated at the time of listing by the LTRS.  相似文献   
83.
Viral B and C hepatitis are a major current health issue, both diseases having a chronic damaging effect on the liver and its functions. Chronic liver disease can lead to even more severe and life-threatening conditions, such as liver cirrhosis and hepatocellular carcinoma. Recent years have uncovered an important interplay between the liver and the gut microbiome: the gut-liver axis. Hepatitis B and C infections often cause alterations in the gut microbiota by lowering the levels of ‘protective’ gut microorganisms and, by doing so, hinder the microbiota ability to boost the immune response. Treatments aimed at restoring the gut microbiota balance may provide a valuable addition to current practice therapies and may help limit the chronic changes observed in the liver of hepatitis B and C patients. This review aims to summarize the current knowledge on the anato-functional axis between the gut and liver and to highlight the influence that hepatitis B and C viruses have on the microbiota balance, as well as the influence of treatments aimed at restoring the gut microbiota on infected livers and disease progression.  相似文献   
84.
85.
86.
87.
88.
89.
Mutaz Dana 《Hemoglobin》2018,42(2):138-140
The major hemoglobin (Hb) during fetal life is fetal Hb (Hb F). It is mostly replaced by adult Hbs before birth and during the first year of life. In adults, where Hb F comprises <2.0% of the total Hb, it is not homogenously distributed among the red blood cells (RBCs) but is concentrated in a few RBCs, termed F-cells. Interestingly, for reasons that are unclear, Hb F increases in the maternal circulation during pregnancy. This increased Hb F could have two potential origins that are not mutually exclusive: A) maternal origin, due to inducing environment of Hb F in the maternal erythroid precursors; B) fetal origin, due to fetal cells crossing the placenta and entering the maternal circulation. The question we present herein is whether the observed increased Hb F in the maternal circulation during pregnancy is, at least partially, derived from the fetal origin. Peripheral blood was obtained from normal neonates (1–3 days old), adult men and pregnant and non pregnant women. The RBCs were stained for Hb F and carbonic anhydrase (CA) using a fetal cell count kit and analyzed by flow cytometry. Fetal and adult F-cells were distinguished by their expression of Hb F and CA. Fetal F-cells were Hb F++/CA?, while adult F-cells were Hb F+/CA+. Comparing pregnant and non pregnant women samples (n?=?10), we found six samples of pregnant women with 0.2–1.7% fetal cells, but none in the non pregnant group. These results support the possibility that at least part of the increase in Hb F during pregnancy is due to fetal cells entering the maternal circulation.  相似文献   
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号